Murine Major Histocompatibility Complex class II (MHC II) (MHC II)

Murine Major Histocompatibility Complex class II (MHC II) molecules, primarily comprising the I-A and I-E heterodimers, are cell surface glycoproteins essential for the initiation of adaptive immune responses (Janeway et al., Immunobiology, 2001). They are expressed on professional antigen-presenting cells (APCs) such as dendritic cells and B cells, where they present processed exogenous peptides to the T-cell receptors (TCRs) of CD4+ T-helper cells (Unanue, Nature, 1984). The term "Other murine MHC class II alleles" typically serves as a collective designation for the diverse polymorphic variants found across different mouse strains, such as H-2b or H-2d, which are not specifically identified in broader datasets (ChEMBL, 2024). These molecules play a pivotal role in the development of autoimmune conditions and the rejection of transplanted tissues, making them significant targets for immunomodulatory research (Taneja & David, Immunological Reviews, 1998). Therapeutic intervention often involves the use of monoclonal antibodies, such as M5/114.15.2, to block the MHC-TCR interface and suppress unwanted immune activation (Bhattacharya et al., Journal of Immunology, 1981). Understanding the specific allele is crucial in drug development, as the structural variations in the peptide-binding groove directly influence the efficacy of antigen presentation and the potency of potential therapeutic agents (Guermonprez et al., Annual Review of Immunology, 2002).

Other names

H-2 class IIMouse MHC III-A/I-E moleculesMurine Histocompatibility-2 complex class IIIa antigensMurine MHC class II alleles

Modulation of the interaction between antigen-presenting cells and CD4+ T-helper cells by blocking the MHC-peptide complex from binding to the T-cell receptor (TCR).